Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-114969
Filing Date
2018-04-12
Accepted
2018-04-12 08:50:56
Documents
12
Effectiveness Date
2018-04-12

Document Format Files

Seq Description Document Type Size
1 DEFA14A d565020ddefa14a.htm DEFA14A 30562
2 GRAPHIC g565020g87b92.jpg GRAPHIC 24955
3 GRAPHIC g565020na1.jpg GRAPHIC 38902
4 GRAPHIC g565020na2.jpg GRAPHIC 24876
5 GRAPHIC g565020na4.jpg GRAPHIC 11002
6 GRAPHIC g565020na5.jpg GRAPHIC 3678
7 GRAPHIC g565020na6.jpg GRAPHIC 5448
8 GRAPHIC g565020na7.jpg GRAPHIC 5216
9 GRAPHIC g565020na8.jpg GRAPHIC 10287
10 GRAPHIC g565020new1.jpg GRAPHIC 17245
11 GRAPHIC g565020new2.jpg GRAPHIC 13052
12 GRAPHIC g565020pc22.jpg GRAPHIC 5520
  Complete submission text file 0001193125-18-114969.txt   253628
Mailing Address 210 E. GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 210 E. GRAND AVE SOUTH SAN FRANCISCO CA 94080 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0102
Type: DEFA14A | Act: 34 | File No.: 000-30235 | Film No.: 18751229
SIC: 8731 Services-Commercial Physical & Biological Research